26 July 2022 in Poultry Science
LMLizbeth Mendoza-González
+5
The avian infectious bronchitis virus (IBV) is a highly mutable coronavirus that causes an acute and highly contagious disease responsible for economic losses to the poultry industry worldwide. Preventing and controlling bronchitis disease is difficulted by the numerous IBV circulating types with limited antigenic cross-protection that hamper the prevention and control by heterologous vaccines. The coding region of the variable spike S1 receptor-attachment domain is used to classify IBV in 7 genotypes (GI–GVII) comprising 35 viral lineages (1–35). Knowledge of the circulating IBV types causing outbreaks in a specific geographic region is beneficial to select better the appropriate vaccine(s) and contribute to disease control. In the study, 17 avian infectious bronchitis virus strains were obtained from chickens showing signs of illness in Mexico from 2007 to 2021. We detected 4 lineages within genotype I, three already known (GI-3, GI-9, GI-13) and one newly described (GI-30). In addition, we identified 2 divergent monophyletic groups that are tentatively described as lineages of new genotypes (GVIII-1 and GIX-1). Our findings revealed that Mexico's high genetic IBV diversity results from the co-circulation of divergent lineages belonging to different genotypes. Mexican IBV lineages differ significantly from Massachusetts and Connecticut vaccine strains, indicating that the currently used vaccines may need to be updated.
21 February 2025 in Veterinaria México OA
Reproductive control of invasive, feral, and domesticated animals is an urgent public health issue. Immunological vaccines are employed as an emerging strategy to target different components of the reproductive system, to achieve immunocastration. Successful use of immunogens against parts of the oocyte, spermatozoon, gonadotropin-releasing hormone (GnRH), and luteinizing hormone receptor (LHr) has been reported. In this work, a recombinant DNA vaccine was prepared (P2GnRHrP30) by the fusion of the first extracellular domain of the canine GnRH receptor (GNRHr) gene to the P2 and P30 tetanus toxoid epitopes. This construction was cloned in the pCI-NEO mammalian expression vector and evaluated as an immunocontraception DNA vaccine in male mice. The developed vaccine was demonstrated to be safe, and capable of reducing serum testosterone levels and causing testicular atrophy. Our work indicates that the first extracellular domain of the GnRHr gene may act as an immune target for reproductive control and potentially be used as a non-surgical sterilization procedure in mammals.